Many miRNAs have been indicated as positive modulators in ameliorating pathogenesis in AD and PD; for example, overexpressing miR-34a has been indicated to reduce tau synthesis in AD by binding to the 3′ UTR of human tau mRNA [179]. This evidence concerns the gene MAPT and Parkinson disease.